Chimeric Antigen Receptor T-Cell Therapy: More Than an Anti-Cancer Drug.

Schenk HCM, Gille I, Arana C, Rovira J, Palou E, Diekmann F, Roelen DL, Heemskerk MHM, Heidt S

DOI: 10.1111/tan.70550
Published: 2026 Jan
Container: HLA
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/tan.70550,
  title = {Chimeric Antigen Receptor T-Cell Therapy: More Than an Anti-Cancer Drug.},
  author = {Schenk HCM and Gille I and Arana C and Rovira J and Palou E and Diekmann F and Roelen DL and Heemskerk MHM and Heidt S},
  year = {2026},
  journal = {HLA},
  doi = {10.1111/tan.70550},
  url = {https://doi.org/10.1111/tan.70550}
}

RIS

TY  - JOUR
TI  - Chimeric Antigen Receptor T-Cell Therapy: More Than an Anti-Cancer Drug.
AU  - Schenk HCM
AU  - Gille I
AU  - Arana C
AU  - Rovira J
AU  - Palou E
AU  - Diekmann F
AU  - Roelen DL
AU  - Heemskerk MHM
AU  - Heidt S
PY  - 2026
JO  - HLA
DO  - 10.1111/tan.70550
UR  - https://doi.org/10.1111/tan.70550
ER  -

APA

HCM, S., I, G., C, A., J, R., E, P., F, D., DL, R., MHM, H., & S, H. (2026). Chimeric Antigen Receptor T-Cell Therapy: More Than an Anti-Cancer Drug.. HLA. https://doi.org/10.1111/tan.70550

Source records

pubmed · retrieved 2026-09-27T08:42:41.844Z